These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20664168)

  • 1. Seeing red: flushing out instigators of niacin-associated skin toxicity.
    Dunbar RL; Gelfand JM
    J Clin Invest; 2010 Aug; 120(8):2651-5. PubMed ID: 20664168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice.
    Hanson J; Gille A; Zwykiel S; Lukasova M; Clausen BE; Ahmed K; Tunaru S; Wirth A; Offermanns S
    J Clin Invest; 2010 Aug; 120(8):2910-9. PubMed ID: 20664170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of HCA₂ (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin.
    Hanson J; Gille A; Offermanns S
    Pharmacol Ther; 2012 Oct; 136(1):1-7. PubMed ID: 22743741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring niacin-associated skin toxicity (NASTy) stigmata along with symptoms to aid development of niacin mimetics.
    Dunbar RL; Goel H; Tuteja S; Song WL; Nathanson G; Babar Z; Lalic D; Gelfand JM; Rader DJ; Grove GL
    J Lipid Res; 2017 Apr; 58(4):783-797. PubMed ID: 28119443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.
    Benyó Z; Gille A; Kero J; Csiky M; Suchánková MC; Nüsing RM; Moers A; Pfeffer K; Offermanns S
    J Clin Invest; 2005 Dec; 115(12):3634-40. PubMed ID: 16322797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Niacin inhibits skin dendritic cell mobilization in a GPR109A independent manner but has no impact on monocyte trafficking in atherosclerosis.
    Ingersoll MA; Potteaux S; Alvarez D; Hutchison SB; van Rooijen N; Randolph GJ
    Immunobiology; 2012 May; 217(5):548-57. PubMed ID: 21798616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Langerhans cells release prostaglandin D2 in response to nicotinic acid.
    Maciejewski-Lenoir D; Richman JG; Hakak Y; Gaidarov I; Behan DP; Connolly DT
    J Invest Dermatol; 2006 Dec; 126(12):2637-46. PubMed ID: 17008871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents?
    Kamanna VS; Kashyap ML
    Am J Cardiol; 2007 Dec; 100(11 A):S53-61. PubMed ID: 18047854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-guided engineering of biased-agonism in the human niacin receptor via single amino acid substitution.
    Yadav MK; Sarma P; Maharana J; Ganguly M; Mishra S; Zaidi N; Dalal A; Singh V; Saha S; Mahajan G; Sharma S; Chami M; Banerjee R; Shukla AK
    Nat Commun; 2024 Mar; 15(1):1939. PubMed ID: 38431681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism and mitigation of niacin-induced flushing.
    Kamanna VS; Ganji SH; Kashyap ML
    Int J Clin Pract; 2009 Sep; 63(9):1369-77. PubMed ID: 19691622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future of GPR109A agonists in the treatment of dyslipidaemia.
    Wanders D; Judd RL
    Diabetes Obes Metab; 2011 Aug; 13(8):685-91. PubMed ID: 21418500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Niacin: an old drug rejuvenated.
    Kamanna VS; Ganji SH; Kashyap ML
    Curr Atheroscler Rep; 2009 Jan; 11(1):45-51. PubMed ID: 19080727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinic acid: recent developments.
    Kamanna VS; Vo A; Kashyap ML
    Curr Opin Cardiol; 2008 Jul; 23(4):393-8. PubMed ID: 18520725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells.
    Benyó Z; Gille A; Bennett CL; Clausen BE; Offermanns S
    Mol Pharmacol; 2006 Dec; 70(6):1844-9. PubMed ID: 17008386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid.
    Pike NB
    J Clin Invest; 2005 Dec; 115(12):3400-3. PubMed ID: 16322787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of soluble epoxide hydrolase limits niacin-induced vasodilation in mice.
    Inceoglu AB; Clifton HL; Yang J; Hegedus C; Hammock BD; Schaefer S
    J Cardiovasc Pharmacol; 2012 Jul; 60(1):70-5. PubMed ID: 22526297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid.
    Morrow JD; Parsons WG; Roberts LJ
    Prostaglandins; 1989 Aug; 38(2):263-74. PubMed ID: 2475889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in rats.
    Shen HC; Ding FX; Deng Q; Wilsie LC; Krsmanovic ML; Taggart AK; Carballo-Jane E; Ren N; Cai TQ; Wu TJ; Wu KK; Cheng K; Chen Q; Wolff MS; Tong X; Holt TG; Waters MG; Hammond ML; Tata JR; Colletti SL
    J Med Chem; 2009 Apr; 52(8):2587-602. PubMed ID: 19309152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pyrazole partial agonists on HCA(2) -mediated flushing and VLDL-triglyceride levels in mice.
    Li Z; Blad CC; van der Sluis RJ; de Vries H; Van Berkel TJ; Ijzerman AP; Hoekstra M
    Br J Pharmacol; 2012 Oct; 167(4):818-25. PubMed ID: 22616721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aspirin when added to the prostaglandin D2 receptor antagonist laropiprant on niacin-induced flushing symptoms.
    Dishy V; Liu F; Ebel DL; Atiee GJ; Royalty J; Reilley S; Paolini JF; Wagner JA; Lai E
    J Clin Pharmacol; 2009 Apr; 49(4):416-22. PubMed ID: 19246721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.